Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$125M Sell
343,948
-322,502
-48% -$110M 1.46% 24
2026
Q1
$234M Buy
666,450
+10,939
+2% +$3.9M 2.86% 11
2025
Q4
$215M Sell
655,511
-4,482
-0.7% -$1.42M 2.23% 18
2025
Q3
$181M Buy
659,993
+47,873
+8% +$13.9M 1.77% 24
2025
Q2
$171M Buy
612,120
+54,580
+10% +$15.5M 1.7% 25
2025
Q1
$174M Buy
557,540
+25,241
+5% +$7.45M 1.88% 25
2024
Q4
$139M Sell
532,299
-286,101
-35% -$84.9M 1.53% 23
2024
Q3
$264M Sell
818,400
-310,136
-27% -$101M 2.49% 19
2024
Q2
$353M Sell
1,128,536
-12,857
-1% -$3.78M 3.12% 12
2024
Q1
$325M Sell
1,141,393
-6,300
-0.5% -$1.84M 3.2% 11
2023
Q4
$331M Sell
1,147,693
-36,118
-3% -$9.84M 3.63% 6
2023
Q3
$318M Sell
1,183,811
-59,287
-5% -$14.8M 3.97% 7
2023
Q2
$276M Sell
1,243,098
-1,239,047
-50% -$288M 3.2% 9
2023
Q1
$580M Buy
2,482,145
+1,514,172
+156% +$372M 3.12% 9
2022
Q4
$254M Sell
967,973
-24,789
-2% -$6.64M 3.33% 8
2022
Q3
$224M Sell
992,762
-326,209
-25% -$79.1M 3.1% 10
2022
Q2
$321M Sell
1,318,971
-44,636
-3% -$10.9M 4.05% 5
2022
Q1
$330M Sell
1,363,607
-5,828
-0.4% -$1.34M 3.32% 7
2021
Q4
$308M Buy
1,369,435
+165,636
+14% +$35M 2.81% 13
2021
Q3
$256M Buy
1,203,799
+40,507
+3% +$9.32M 2.58% 16
2021
Q2
$284M Buy
1,163,292
+64,592
+6% +$15.9M 2.96% 10
2021
Q1
$273M Buy
1,098,700
+43,409
+4% +$10.4M 3.22% 9
2020
Q4
$243M Buy
1,055,291
+99,942
+10% +$23M 3.21% 8
2020
Q3
$243M Sell
955,349
-10,816
-1% -$2.68M 3.51% 5
2020
Q2
$228M Sell
966,165
-42,703
-4% -$9.74M 3.64% 5
2020
Q1
$205M Sell
1,008,868
-67,122
-6% -$14.7M 4.02% 3
2019
Q4
$259M Buy
1,075,990
+4,667
+0.4% +$1.03M 3.96% 2
2019
Q3
$207M Buy
1,071,323
+106,302
+11% +$20.4M 3.43% 6
2019
Q2
$178M Buy
965,021
+44,977
+5% +$8.05M 3.11% 10
2019
Q1
$175M Buy
920,044
+57,152
+7% +$10.9M 3.37% 9
2018
Q4
$168M Buy
862,892
+6,960
+0.8% +$1.36M 3.65% 6
2018
Q3
$177M Sell
855,932
-120,067
-12% -$23.7M 3.34% 8
2018
Q2
$180M Buy
975,999
+7,660
+0.8% +$1.35M 3.54% 5
2018
Q1
$165M Buy
968,339
+49,426
+5% +$9.07M 3.23% 7
2017
Q4
$160M Sell
918,913
-6,104
-0.7% -$1.08M 3.1% 9
2017
Q3
$172M Sell
925,017
-53,018
-5% -$9.39M 3.48% 5
2017
Q2
$168M Sell
978,035
-20,716
-2% -$3.37M 3.3% 6
2017
Q1
$164M Sell
998,751
-373,925
-27% -$62.1M 3.19% 6
2016
Q4
$201M Buy
1,372,676
+32,811
+2% +$4.94M 3.39% 3
2016
Q3
$224M Buy
1,339,865
+18,141
+1% +$3.07M 3.5% 5
2016
Q2
$201M Sell
1,321,724
-178,880
-12% -$27.8M 3.34% 5
2016
Q1
$225M Sell
1,500,604
-10,562
-0.7% -$1.57M 3.67% 4
2015
Q4
$245M Sell
1,511,166
-35,209
-2% -$5.53M 4.08% 4
2015
Q3
$214M Buy
1,546,375
+239,652
+18% +$37.8M 3.85% 6
2015
Q2
$201M Sell
1,306,723
-164,826
-11% -$26.4M 3.29% 9
2015
Q1
$235M Sell
1,471,549
-16,413
-1% -$2.58M 3.6% 8
2014
Q4
$237M Sell
1,487,962
-912,384
-38% -$142M 3.54% 8
2014
Q3
$337M Sell
2,400,346
-45,930
-2% -$6M 4.64% 3
2014
Q2
$290M Buy
2,446,276
+105,652
+5% +$12.2M 4.05% 6
2014
Q1
$289M Buy
2,340,624
+100,056
+4% +$12.1M 4.12% 6
2013
Q4
$256M Buy
2,240,568
+455,205
+25% +$51.8M 3.58% 8
2013
Q3
$200M Buy
1,785,363
+533,755
+43% +$57.9M 3.05% 9
2013
Q2
$123M Buy
+1,251,608
New +$130M 1.76% 23

Other funds holding AMGN

Sarasin & Partners's AMGN Position: Q2 2026 in Review

Sarasin & Partners reduced its Amgen (AMGN) stake by 48% in Q2 2026, selling an estimated $110M and leaving 343,948 shares worth $125M. The position accounts for 1.46% of the portfolio, ranked #24.

Sarasin & Partners first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $580M in Q1 2023. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sarasin & Partners held 343,948 shares of Amgen worth $125M as of Q2 2026.
  • Sarasin & Partners sold 322,502 Amgen shares in Q2 2026, an estimated $110M.
  • Amgen made up 1.46% of Sarasin & Partners's portfolio in Q2 2026, its #24 holding.
  • Sarasin & Partners first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Sarasin & Partners's Amgen position peaked at $580M in Q1 2023.
  • 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sarasin & Partners's 13F filing for Q2 2026, filed 7 Jul 2026.